Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence van Hunsel

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Drug Safety|September 12, 2024
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied WorldwideCorine Ekhart, Sjoerd H P Wiarda, Sonja van de Koppel, et al.
Vaccines|January 22, 2024
Changes in Local and Systemic Adverse Effects following Primary and Booster Immunisation against COVID-19 in an Observational Cohort of Dutch Healthcare Workers Vaccinated with BNT162b2 (Comirnaty<sup>®</sup>)Christiaan Serbanescu-Kele Apor de Zalán, Maud Bouwman, Frits van Osch, et al.
Drug Safety|April 6, 2023
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseMonika Raethke, Florence van Hunsel, Nicolas H Thurin, et al.
Vaccines|March 28, 2024
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country StudyFrancesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
Vaccine|March 6, 2024
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring studyMonika Raethke, Florence van Hunsel, Nicoletta Luxi, et al.
Vaccines|September 28, 2024
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance StudyNicoletta Luxi, Francesco Ciccimarra, Chiara Bellitto, et al.
Drug Safety|June 22, 2024
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance StudyChiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, et al.
The Lancet Regional Health. Europe|December 24, 2021
Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sourcesLinda Davidson, Juul M P A van den Reek, Mariolina Bruno, et al.
Frontiers in Drug Safety and Regulation|January 14, 2026
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant womenEmeline Maisonneuve, Nicoletta Luxi, Chiara Bellitto, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Drug Safety|September 12, 2024
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied WorldwideCorine Ekhart, Sjoerd H P Wiarda, Sonja van de Koppel, et al.
Vaccines|January 22, 2024
Changes in Local and Systemic Adverse Effects following Primary and Booster Immunisation against COVID-19 in an Observational Cohort of Dutch Healthcare Workers Vaccinated with BNT162b2 (Comirnaty<sup>®</sup>)Christiaan Serbanescu-Kele Apor de Zalán, Maud Bouwman, Frits van Osch, et al.
Drug Safety|April 6, 2023
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseMonika Raethke, Florence van Hunsel, Nicolas H Thurin, et al.
Vaccines|March 28, 2024
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country StudyFrancesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
Vaccine|March 6, 2024
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring studyMonika Raethke, Florence van Hunsel, Nicoletta Luxi, et al.
Vaccines|September 28, 2024
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance StudyNicoletta Luxi, Francesco Ciccimarra, Chiara Bellitto, et al.
Drug Safety|June 22, 2024
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance StudyChiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, et al.
The Lancet Regional Health. Europe|December 24, 2021
Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sourcesLinda Davidson, Juul M P A van den Reek, Mariolina Bruno, et al.
Frontiers in Drug Safety and Regulation|January 14, 2026
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant womenEmeline Maisonneuve, Nicoletta Luxi, Chiara Bellitto, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 10